<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>阿基米德Biotech | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-25T20:26:40+08:00</updated>
  <subtitle>专注生物医药、医疗器械，兼顾低风险机会，长线持有优质公司，做时间的朋友，共勉同行</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>揭示A股季节规律，下月初“三大惊奇”，15只药械股却逆势新高</title>
    <updated>2020-10-25T11:27:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/FrXBZjCgqfcylxzTBvIT_A</id>
    <link href="https://mp.weixin.qq.com/s/FrXBZjCgqfcylxzTBvIT_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>做客雪球访谈：恒瑞医药何时破万亿市值，还分析了你关心的20只药械股</title>
    <updated>2020-10-22T03:52:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/DOT0e8YBP4dC3mwjEpSlwA</id>
    <link href="https://mp.weixin.qq.com/s/DOT0e8YBP4dC3mwjEpSlwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CXO泡沫浴：分享创新药红利的最好方式</title>
    <updated>2020-10-21T21:42:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/ayq1mGlohRrAfhIdphS8Hg</id>
    <link href="https://mp.weixin.qq.com/s/ayq1mGlohRrAfhIdphS8Hg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采囚徒困境：细解医疗器械受影响赛道和公司</title>
    <updated>2020-10-18T14:53:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-18:/s/CCmEfJLvbzgFD7B13ZGsOw</id>
    <link href="https://mp.weixin.qq.com/s/CCmEfJLvbzgFD7B13ZGsOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么说药不如械？长逻辑再梳理</title>
    <updated>2020-10-16T20:41:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-16:/s/zlBrzqVRQBoCkwxF4ylC8g</id>
    <link href="https://mp.weixin.qq.com/s/zlBrzqVRQBoCkwxF4ylC8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药盛世危言：百济巨婴</title>
    <updated>2020-10-14T20:00:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-14:/s/mf7KVozzZ-srjxv3c9LP5Q</id>
    <link href="https://mp.weixin.qq.com/s/mf7KVozzZ-srjxv3c9LP5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>长期不断新高是选股的重要标准</title>
    <updated>2020-10-12T20:08:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-12:/s/8hAEJ3DGHS8jfix_0M0Puw</id>
    <link href="https://mp.weixin.qq.com/s/8hAEJ3DGHS8jfix_0M0Puw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谁能挑战爱尔眼科？</title>
    <updated>2020-10-09T19:11:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-09:/s/PziUcHBIRJnd5C4VHLOkxw</id>
    <link href="https://mp.weixin.qq.com/s/PziUcHBIRJnd5C4VHLOkxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>眼科赛道就可以为所欲为？</title>
    <updated>2020-10-07T12:30:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-07:/s/u9lPYSsKKJu6GP29enZIgA</id>
    <link href="https://mp.weixin.qq.com/s/u9lPYSsKKJu6GP29enZIgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>备战节后，港股已具罕见投资价值？10只药械股分析</title>
    <updated>2020-10-02T10:54:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-02:/s/nlo93kS1sbaTMek7L_ihrg</id>
    <link href="https://mp.weixin.qq.com/s/nlo93kS1sbaTMek7L_ihrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>